Disease modelling of a phospholamban p.Arg14del mutation in hiPSC-derived cardiomyocytes
- Alternative title
-
Krankheitsmodellierung der Phospholamban p.Arg14del-Mutation in humanen induzierten pluripotenten Stammzell-abgeleiteten Kardiomyozyten
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Hamburg, Universität Hamburg, Dissertation, 2018
- Classification
-
Naturwissenschaften
- Keyword
-
Induzierte pluripotente Stammzelle ; Tissue Engineering ; CRISPR/Cas-Methode ; Phospholamban ; Zelldifferenzierung ; Genome Editing
- Event
-
Veröffentlichung
- (where)
-
Hamburg
- (who)
-
Staats- und Universitätsbibliothek Hamburg
- (when)
-
2018
- Creator
-
Knaust, Anika Eike
- Contributor
-
Oetjen, Elke
- URN
-
urn:nbn:de:gbv:18-91117
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Knaust, Anika Eike
- Oetjen, Elke
- Staats- und Universitätsbibliothek Hamburg
Time of origin
- 2018
Other Objects (12)
Electromechanical model of hiPSC-derived ventricular cardiomyocytes cocultured with fibroblasts
Direct 3D‐Bioprinting of hiPSC‐Derived Cardiomyocytes to Generate Functional Cardiac Tissues
Disease modelling and molecular therapy of severe cardiomyopathy in hiPSC-derived cardiomyocytes carrying bi-allelic truncating MYBPC3 mutations
Dynamic changes in LINC00458/HBL1 lncRNA expression during hiPSC differentiation to cardiomyocytes
Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
Electromechanical modelling and simulation of hiPSC-derived cardiac cell cultures
Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts
Modelling and Simulation for Preclinical Cardiac Safety Assessment of Drugs with Human iPSC-Derived Cardiomyocytes
Reaktive Sauerstoffspezies in hiPSC abgeleiteten Kardiomyozyten einer ARVC Patientin mit Plakophilin 2 Mutation
ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes
Electromechanical model of hiPSC-derived ventricular cardiomyocytes cocultured with fibroblasts
Direct 3D‐Bioprinting of hiPSC‐Derived Cardiomyocytes to Generate Functional Cardiac Tissues
Disease modelling and molecular therapy of severe cardiomyopathy in hiPSC-derived cardiomyocytes carrying bi-allelic truncating MYBPC3 mutations
Dynamic changes in LINC00458/HBL1 lncRNA expression during hiPSC differentiation to cardiomyocytes
Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
Electromechanical modelling and simulation of hiPSC-derived cardiac cell cultures
Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts
Modelling and Simulation for Preclinical Cardiac Safety Assessment of Drugs with Human iPSC-Derived Cardiomyocytes
Reaktive Sauerstoffspezies in hiPSC abgeleiteten Kardiomyozyten einer ARVC Patientin mit Plakophilin 2 Mutation
ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes
Electromechanical model of hiPSC-derived ventricular cardiomyocytes cocultured with fibroblasts
Direct 3D‐Bioprinting of hiPSC‐Derived Cardiomyocytes to Generate Functional Cardiac Tissues
Disease modelling and molecular therapy of severe cardiomyopathy in hiPSC-derived cardiomyocytes carrying bi-allelic truncating MYBPC3 mutations
Dynamic changes in LINC00458/HBL1 lncRNA expression during hiPSC differentiation to cardiomyocytes
Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
Electromechanical modelling and simulation of hiPSC-derived cardiac cell cultures
Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts
Modelling and Simulation for Preclinical Cardiac Safety Assessment of Drugs with Human iPSC-Derived Cardiomyocytes
Reaktive Sauerstoffspezies in hiPSC abgeleiteten Kardiomyozyten einer ARVC Patientin mit Plakophilin 2 Mutation